Omniscope

About:

Building the world's largest immune databank.

Top Investors: European Commission, Medical Research Future Fund (MRFF), Horizon Europe, FoundersX Ventures, Friends & Family

Description:

TechBio company decoding the immune system in high resolution to inform therapy and develop diagnostics through the convergence of immune cell sequencing and artificial intelligence. For more information: https://www.omniscope.ai/immune-portal

Total Funding Amount:

$8.62M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Delaware City, Delaware, United States

Founded Date:

2021-02-25

Contact Email:

hello(AT)omniscope.ai

Founders:

Holger Heyn, Lynnette Ang, Vijay Vaswani

Number of Employees:

11-50

Last Funding Date:

2024-06-01

IPO Status:

Private

Industries: